Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

bosentan

EU orphan designation number: EU/3/08/559
Active ingredient: bosentan
Indication: Treatment of idiopathic pulmonary fibrosis
Sponsor: Actelion Registration Ltd
BSI Building 13th Floor, 389 Chiswick High Road, London W4 4AL, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/09/2008 Centralised Orphan - Designation EMEA/OD/027/08 (2008)5020 of 05/09/2008
04/04/2014 Centralised Orphan - Removal of orphan designation from Community Register